OSE Pharma SA Asset Resilience Ratio

Latest as of June 2025: 29.41%

OSE Pharma SA asset resilience ratio. OSE Pharma SA (OSE) has an Asset Resilience Ratio of 29.41% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See OSE Pharma SA (OSE) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€30.64 Million

≈ $35.82 Million USD Cash + Short-term Investments

Total Assets

€104.18 Million

≈ $121.80 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of OSE Pharma SA (2015–2024)

Asset resilience ratio of OSE Pharma SA from 2015 to 2024. This chart shows how OSE Pharma SA's Asset Resilience Ratio has changed over time. Read debt load of OSE Pharma SA for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down OSE Pharma SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see OSE total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€14.44 Million	13.86%
Short-term Investments	€16.20 Million	15.55%
Total Liquid Assets	€30.64 Million	29.41%

Asset Resilience Insights

Very High Liquidity: OSE Pharma SA maintains exceptional liquid asset reserves at 29.41% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

OSE Pharma SA Industry Peers by Asset Resilience Ratio

Compare OSE Pharma SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

OSE Pharma SA Asset Resilience Ratio by Year (2015–2024)

OSE Pharma SA asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for OSE Pharma SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	41.70%	€51.69 Million ≈ $60.43 Million	€123.96 Million ≈ $144.92 Million	+26.38pp
2023-12-31	15.32%	€12.57 Million ≈ $14.69 Million	€82.05 Million ≈ $95.93 Million	+7.56pp
2022-12-31	7.75%	€7.11 Million ≈ $8.31 Million	€91.67 Million ≈ $107.17 Million	-25.10pp
2021-12-31	32.85%	€33.35 Million ≈ $38.99 Million	€101.52 Million ≈ $118.69 Million	+3.00pp
2020-12-31	29.86%	€28.91 Million ≈ $33.80 Million	€96.85 Million ≈ $113.22 Million	+1.01pp
2019-12-31	28.85%	€25.64 Million ≈ $29.98 Million	€88.89 Million ≈ $103.92 Million	+18.50pp
2018-12-31	10.35%	€7.96 Million ≈ $9.30 Million	€76.90 Million ≈ $89.91 Million	-2.96pp
2017-12-31	13.31%	€10.29 Million ≈ $12.03 Million	€77.35 Million ≈ $90.43 Million	-6.53pp
2016-12-31	19.84%	€17.77 Million ≈ $20.77 Million	€89.55 Million ≈ $104.69 Million	-14.29pp
2015-12-31	34.13%	€5.80 Million ≈ $6.78 Million	€17.00 Million ≈ $19.87 Million	--

pp = percentage points

About OSE Pharma SA

PA:OSE France Biotechnology

Market Cap

$46.24 Million

€39.55 Million EUR

Market Cap Rank

#22013 Global

#343 in France

Share Price

€1.76

Change (1 day)

-3.87%

52-Week Range

€1.76 - €5.71

All Time High

€15.00